芬氟拉明联合达美康治疗Ⅱ型糖尿病疗效观察  

CURATIVE EFFECT OBSERVATION: USING FENFLURAMINE COOPERATEDWITH DIAMICRON TO TREAT TYPE Ⅱ DIABETES

作　　者：李金亮[1] 胡仁欣[1] 梁景荣[1] 

机构地区：[1]临沂市人民医院

出　　处：《临沂医学专科学校学报》1995年第4期291-293,共3页Journal of Linyi Medical College

摘　　要：木文对６５例Ⅱ型糖尿病肥胖病人，随机分为治疗组３５例，对照组３Ｏ例。两组空腹和饭后２小时血糖无差异（Ｐ＞０．０５）。在统一饮食治疗基础上，治疗组口服芬氟拉明和达美康，对照组口服过美康。２周和４周后分别测空腹和饭后２小时血糖，组间均数比较ｔ检验，Ｐ＜０．０１，表明芬氟拉明达美康合用降糖作用显著，优于单用达美康。The People's Hospital of Linyi District, Shandong 65 cases of type ⅡQiabetes were divided. Randomly into two groups: treated group (35 cases) and control one (30 cases). Blood sugar densitys of two groups have no statistical difference on empty stomach and 2 hours after meal. In the foundation of unified dietotherapy, patients of treated group take fenfluramine and diamicron orally; bait patients of control one take diamicron only. After 2 or 4 weeks of treatment, the authors respectively examined their blood sugar densitys on empty stomach and 2 hours after meal, by 'Ttestn'of equal numeral comparison between these two groups, calculated p <0. 01 at last, then concluded that taking both fenfluramine and diamicron has more advantage in lower the blood sugar density than diamicron only.

关 键 词：糖尿病 血糖 芬氟拉明 达美康 治疗 

分 类 号：R587.105[医药卫生—内分泌]